| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 08/15/2006 | US7091232 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 08/15/2006 | US7091223 Autoimmune diseases; anticancer agents |
| 08/15/2006 | US7091217 Chemokine receptor binding heterocyclic compounds |
| 08/15/2006 | US7091216 antagonists of the Cannabinoid-1 (CB1) receptor; treating obesity |
| 08/15/2006 | US7091209 Dihydroxypyridmidine carboxylic acids as viral polymerase inhibitors |
| 08/15/2006 | US7091204 Sulfonamides |
| 08/15/2006 | US7091201 Arylalkane-sulfonamides having endothelin-antagonist activity |
| 08/15/2006 | US7091158 Substituted thienyl(amino)sulphonylureas |
| 08/10/2006 | WO2006083841A2 Therapeutic esters |
| 08/10/2006 | WO2006083673A2 Pyridine derivatives useful as inhibitors of c-jun n-terminal kinases |
| 08/10/2006 | WO2006083454A1 Multicyclic bis-amide mmp inhibitors |
| 08/10/2006 | WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/10/2006 | WO2006082952A1 Amide compound |
| 08/10/2006 | WO2006082392A1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors |
| 08/10/2006 | WO2006082371A1 Pyrimidine compounds having tie2 (tek) inhibitory activity |
| 08/10/2006 | WO2006082001A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 08/10/2006 | WO2006066778A3 Novel heteroarylacetamides |
| 08/10/2006 | WO2006053778A3 Amide derivatives, their manufacture and use as pharmaceutical agents |
| 08/10/2006 | WO2005024440A3 Polarizing agents for dynamic nuclear polarization |
| 08/10/2006 | US20060178513 Pyridinylanilides |
| 08/10/2006 | US20060178490 Catalysts containing N-pyrrolyl substituted nitrogen donors |
| 08/10/2006 | US20060178429 2-Phenyl-3-hydrogenated furanyl, pyranyl, thiophenyl or thiopyranyl-N-heteroaromatic propionamides, e.g., 2-(3,4-Dichloro-phenyl)-3-(tetrahydro-pyran-2-yl)-N-thiazol-2-yl-propionamide; compounds increase insulin secretion in the treatment of type II diabetes. |
| 08/10/2006 | US20060178419 3-Sulfonylamino-pyrrolindine -2- one derivatives as inhibitors of factor xa |
| 08/10/2006 | US20060178418 For therapy of asthma, bronchial asthma, chronic obstructive pulmonary disease, allergic rhinitis, eosinophilic granuloma, nephritis, rheumatoid arthritis, cystic fibrosis, chronic bronchitis, multiple sclerosis, Crohns disease, psoraisis, uticaria, adult vernal conjunctivitis, |
| 08/10/2006 | US20060178416 Quinoline derivatives as phosphodiesterase inhibitors |
| 08/10/2006 | US20060178415 Azole derivatives as antifungal agents |
| 08/10/2006 | US20060178412 [3-(Benzo[b]thiophene-2-carbonyl)-5-(4-methyl phenyl)-1H-indol-1-yl]-acetic acid, for treating conditions resulting from fibrinolytic disorders, such as deep vein thrombosis, coronary heart disease, and pulmonary fibrosis; Alzheimer's disease |
| 08/10/2006 | US20060178410 Preparation of N-{2-[4-(3-phenyl-4-methoxyphenyl)aminophenyl]ethyl}-2-hydroxy-2-(3-hydroxymethyl-4-hydroxyphenyl)ethylamine, for example; for the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease |
| 08/10/2006 | US20060178408 Phosphodiesterases (PDE); for treating respiratory, nervous system, cardiovascular, inflammatory and allergic diseases, disorders and conditions as well as wounds |
| 08/10/2006 | US20060178403 Antiobesity agent, antidepressants, anxiolytic agents;3-[4-OXO-4H-THIENO[3,2-D]PYRIMIDIN-3-YL]-PYRROLIDINE-1-CARBOXYLIC ACID [1-(PYRROLIDIN-3-YL]-METHYL-AMIDES |
| 08/10/2006 | US20060178369 Cinnamic acid amides |
| 08/10/2006 | US20060178366 Compounds for the treatment of inflammatory disorders |
| 08/10/2006 | US20060178365 Optionally oxidized 6-(2-(5-methylthio-2-pyrimidinyloxy)ethoxy)-2-phenylpyrimidin-4-yl-substituted sulfamides |
| 08/10/2006 | US20060178362 Substituted heterocyle fused gamma-carbolines |
| 08/10/2006 | US20060178361 ATM inhibitors |
| 08/10/2006 | US20060178345 Substituted alcohols useful in treatment of Alzheimer's disease |
| 08/10/2006 | CA2596636A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 08/10/2006 | CA2595834A1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors |
| 08/10/2006 | CA2589328A1 Multicyclic bis-amide mmp inhibitors |
| 08/10/2006 | CA2566809A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/09/2006 | EP1688418A2 Chemokine receptor antagonists and methods of use thereof |
| 08/09/2006 | EP1688412A2 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 08/09/2006 | EP1688408A2 Vanilloid receptor ligands and their use in treatments |
| 08/09/2006 | EP1687285A1 Thiazole and pyrazole derivatives as flt-3 kinase inhibitors |
| 08/09/2006 | EP1687277A1 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 08/09/2006 | EP1687002A1 Fused heterocyclic compounds |
| 08/09/2006 | EP1686999A1 Pyrazole derivatives as inhibitors of receptor tyrosine kinases |
| 08/09/2006 | EP1483245B1 5-substituted-alkylaminopyrazole derivatives as pesticides |
| 08/09/2006 | EP1317451B1 Chemokine receptor binding heterocyclic compounds |
| 08/09/2006 | EP1252889B1 Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives |
| 08/09/2006 | EP1140828B1 3-azabicyclo¬3.1.0|hexane derivatives as opiate receptors ligands |
| 08/09/2006 | EP1032393B1 Quinoline-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 08/09/2006 | EP0988301B1 Imidazolyl-cyclic acetals |
| 08/09/2006 | CN1816536A Regulator of cannabinoid receptor |
| 08/09/2006 | CN1816523A N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists |
| 08/09/2006 | CN1814596A Muscarinic agonists |
| 08/09/2006 | CN1814595A Second-order non-linear optical polymer containing azo and thiophene ring, and its synthesizing method and use |
| 08/09/2006 | CN1268614C Substituted pyrazolyl benzsulfamide compound for curing inflammation |
| 08/09/2006 | CN1268333C Indolinone compounds for the treatment of disease |
| 08/08/2006 | US7087750 Such as 1-phenylsulfonyl-4-piperazinylindole hydrochloride for treatment or prophylaxis of disease mediated by serotonin related receptor, obesity, and/or central nervous system disorder |
| 08/08/2006 | US7087638 Plant safening agents; |
| 08/08/2006 | US7087635 3-substituted oxindole β3 agonists |
| 08/08/2006 | US7087631 Aryltetrazole compounds, and compositions thereof |
| 08/08/2006 | US7087628 Heteroaryl and heterocyclic nitrogen ring containing hydrazide compounds useful for treating neurodegenerative disorderes |
| 08/08/2006 | US7087622 Pyridone compounds as inhibitors of bacterial type III protein secreation systems |
| 08/08/2006 | US7087611 Reacting ziprasidone with hydrochloric acid in solvent; salt formation; drying |
| 08/08/2006 | US7087609 3-phenyl-N-{1-[3-(4-pyridin-2-yl-piperazin-1-yl)-phenyl]-ethyl}-acrylamide for example; migraine, neuropathic pain, convulsions, mania, epilepsy, anxiety, depression, bipolar disorder, and neurodegenerative disorders |
| 08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |
| 08/08/2006 | US7087597 Pyrimidine 5-carboxamide compounds, process for producing the same and use thereof |
| 08/08/2006 | US7087596 2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivatives for the treatment of epilepsy and other neurological disorders |
| 08/08/2006 | US7087594 Alkyl ether derivatives or salts thereof |
| 08/08/2006 | CA2282183C Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines |
| 08/08/2006 | CA2253429C 2,4-diaminopyrimidine derivates as dopamine d4 receptor antagonists |
| 08/08/2006 | CA2188835C Novel compounds and methods for synthesis and therapy |
| 08/03/2006 | WO2006081337A2 Erastin analogues and their uses for killing cancer cells |
| 08/03/2006 | WO2006080577A1 Indole derivatives |
| 08/03/2006 | WO2006080450A1 Igf-1r inhibitor |
| 08/03/2006 | WO2006080406A1 Tricyclic compounds |
| 08/03/2006 | WO2006080043A2 Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation |
| 08/03/2006 | WO2006065480A3 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 08/03/2006 | WO2006055708A3 Heterocycle substituted carboxylic acids for the treatment of diabetes |
| 08/03/2006 | WO2006032893A3 Trityl derivatives for enhancing mass spectrometry |
| 08/03/2006 | US20060173061 New beta-agonists, processes for preparing them and their use as pharmaceutical compositions |
| 08/03/2006 | US20060173044 Substituted propargylamines |
| 08/03/2006 | US20060173041 Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors |
| 08/03/2006 | US20060173040 bactericide; derivatives of pseudopeptide Andrimid in which beta-phenylalanine amide is replaced by heteroaromatic or substituted aromatic amide; N-{(1S)-3-[((1S)-1-{[(3R,4S)-1,4-Dimethyl-2,5-dioxo-3-pyrrolidinyl]carbonyl}-2-methylpropyl)amino]-3-oxo-1-phenylpropyl}-2-pyridinecarboxamide; antibiotics |
| 08/03/2006 | US20060173039 Excellent poly (ADP-ribose) synthetase inhibitors; various ischemic diseases, inflammatory diseases, neurodegenerative diseases, diabetes, septic shock, cephalic injury; 1,2-Dihydro-4-[4-(dimethylaminomethyl)phenyl]-5-hydroxy-1-oxoisoquinoline |
| 08/03/2006 | US20060173034 Novel 4-anilinoquinoline-3-carboxamides |
| 08/03/2006 | US20060173027 Spirocvclic piperidines as mch1 antagonists and uses thereof |
| 08/03/2006 | US20060173024 Compositions and methods for treating heart failure |
| 08/03/2006 | US20060173022 Heterocyclic amides, method for the production thereof, substances containing said heterocyclic amides, and use thereof as pesticides |
| 08/03/2006 | US20060173010 Modulators of TNF-alpha signaling |
| 08/03/2006 | US20060173008 New pyridazin-3(2h)-one derivatives |
| 08/03/2006 | US20060173003 4-Heteroarylamino-7-H(hetero)aryl-substituted, e.g., [6-(propane-2-sulfonyl)-pyridin-3-yl]-[7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl ]-amine hydrochloride; the compounds inhibit binding of vanilloid ligands to capsaicin receptors and are used to treat neuropathic pain |
| 08/03/2006 | US20060172988 Azetidine compounds |
| 08/03/2006 | US20060172984 Methods and compositions of novel triazine compounds |
| 08/03/2006 | US20060172358 Novel chemiluminescent compounds and their use |
| 08/03/2006 | CA2596527A1 Igf-1r inhibitors |
| 08/03/2006 | CA2595994A1 Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation |
| 08/03/2006 | CA2595855A1 Pyrazine compounds for inflammation and immune-related uses |